Spruce Biosciences (SPRB) Appoints Dale Hooks as CCO and Reports Narrowed $39M 2025 Net Loss
Spruce Biosciences Inc. (NASDAQ:SPRB) is one of the best hot stocks to buy according to analysts.
Spruce Biosciences Inc. (SPRB)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | AIGH Investment Partners Orin Hirschman | 250,000 | $13,500,000 | 0.85% | |
| 2. | OrbiMed Advisors Samuel Isaly | 200,000 | $10,800,000 | 0.2% | |
| 3. | Millennium Management Israel Englander | 160,981 | $8,692,974 | +44% | 0% |
| 4. | Ikarian Capital Neil Shahrestani | 121,356 | $6,553,224 | 0.71% | |
| 5. | Alyeska Investment Group Anand Parekh | 81,671 | $4,410,234 | +59% | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $17.91 | 256 | $4,585.16 | 1,307 | 2025-10-06 | Filing | |
| $17.91 | 256 | $4,585.16 | 1,307 | 2025-10-06 | Filing | |
| $3.17 | 630,400 | $1,998,368.00 | 1,326,305 | 2023-02-16 | Filing | |
| $3.17 | 2,208,000 | $6,999,360.00 | 6,722,336 | 2023-02-16 | Filing | |
| $15.00 | 250,000 | $3,750,000.00 | 4,989,336 | 2020-10-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $17.46 | 25 | $436.39 | 1,050 | 2025-10-06 | Filing | |
| $19.33 | 232 | $4,483.72 | 1,075 | 2025-10-06 | Filing | |
| $17.46 | 25 | $436.39 | 1,050 | 2025-10-06 | Filing | |
| $19.33 | 232 | $4,483.72 | 1,075 | 2025-10-06 | Filing | |
| $0.75 | 465,021 | $350,951.35 | 2,550,000 | 2024-03-21 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 187,836 | $10,143,144 | 0% | |
| 2. | 146,988 | $7,937,352 | 0.69% | |
| 3. | 119,331 | $6,443,874 | 0% | |
| 4. | 70,548 | $3,809,975 | 0% | |
| 5. | 60,000 | $3,240,000 | 0.07% |
News See All
13 Best Hot Stocks to Buy According to Analysts
On March 6, Dan Niles, Niles Investment Management founder, joined 'Power Lunch' on CNBC to discuss the broader market sell-off and provide a cautious outlook on the current market environment.
Spruce Biosciences (SPRB) Gains FDA Support for Accelerated Approval Pathway
Spruce Biosciences Inc. (NASDAQ:SPRB) is one of the most promising micro-cap stocks according to analysts.
12 Most Promising Micro-Cap Stocks According to Analysts
On February 27, Saira Malik, Nuveen Chief Investment Officer, joined CNBC's 'Closing Bell Overtime' to talk about what to expect from markets in the year to come.
Spruce Biosciences, Inc. (NASDAQ:SPRB) Q1 2023 Earnings Call Transcript
Operator: Welcome to the Spruce Biosciences Investor Call [Operator Instructions]. Please note, this conference call is being recorded.
5 Best Healthcare Stocks Under $20 According to Michael Castor's Sio Capital
In this article, we discuss the 5 best healthcare stocks under $20 according to Michael Castor's Sio Capital.
Hedge Fund Resource Center